483
Sandoz GmbHSandoz GmbH – FDA 483, Dec 17, 2021
Record Details
An FDA inspection of Sandoz GmbH in Kundl, Austria, a drug substance manufacturer, revealed several significant deficiencies. Observations included inadequate inspection of sterile bottles, deficient environmental monitoring, lack of raw material packaging sanitization, and poor facility maintenance in raw material sampling areas. These issues indicate a need for improved quality control and facility management practices.
View Company Profile
ID · 9790dfcf-53b0-4f69-a336-2cf511c6f4cc
Other documents for Sandoz GmbH
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.